LPLaura Jéssica Pereira

Laura Jéssica Pereira

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Laura Jéssica Pereira has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Alternative Model-Based Safety Assessment of a Celtis iguanaea Standardized Spray-Dried Extract

    by Kátia Regina Ribeiro, Rúbia Bellard e Silva, Jéssica Thaianny Ferreira Souza, Laura Jéssica Pereira, Yasmim Raffaela Soares Santos, Emmilly de Oliveira Alves, Jicaury Roberta Pereira da Silva, Mairon César Coimbra, Marina Andrade Rocha, Carolina Girotto Pressete, et al.

    The Celtis iguanaea (Jacq.) Sarg., Cannabaceae, standardized spray-dried extract, underwent acute safety evaluation using a range of alternative toxicological models in alignment with Organization for Economic Co-operation and Development Test Guidelines. Acute aquatic toxicity was assessed using the Artemia salina lethality test (LC 50 418.4 μg/ml) and the zebrafish ( Danio rerio ) embryo toxicity test (OECD TG 236; LC 50 1116.0 μg/ml). According to the Globally Harmonized System aquatic toxicity categories, C. iguanaea spray-dried extract is classified as non-hazardous (LC 50 > 100 μg/ml). In vitro assays included cytotoxicity (methyl thiazolyl tetrazolium assay –in WI-38 and HaCaT cells; resazurin in Caco-2 and HT-29 cells), cell adhesion genotoxicity (comet assay; OECD TG 489), and mutagenicity (cytokinesis-block micronucleus assay; OECD TG 487). Celtis iguanaea spray-dried extract showed no cytotoxic, genotoxic, or mutagenic effects up to 250 μg/ml and enhanced HaCaT cell viability and adhesion at higher concentrations (100 μg/ml), suggesting potential support for wound healing. No antimicrobial activity was observed against Candida spp., ESKAPE pathogens, or bacteria associated with urinary tract infections (MIC > 1024.0 μg/ml). This weight-of-evidence assessment supports the safe use of C. iguanaea spray-dried extract in topical or oral formulations and provides data suitable for regulatory hazard characterization and acute risk assessment. Graphical Abstract

  • Quality-by-design Development of Celtis iguanaea Microparticles with In vivo Gastroprotective Efficacy

    by Rúbia Bellard e Silva, José Luís Rodrigues Martins, Dionys de Souza Almeida, Gabriela Viana Ferreira, Kátia Regina Ribeiro, Mairon César Coimbra, Laura Jéssica Pereira, Emmilly de Oliveira Alves, Marx Osório Araújo Pereira, Eric de Souza Gil, et al.